These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

704 related items for PubMed ID: 20192820

  • 1. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
    Tabarsi P, Chitsaz E, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Amiri M, Mansouri D, Masjedi MR, Velayati AA, Caminero JA.
    Microb Drug Resist; 2010 Mar; 16(1):81-6. PubMed ID: 20192820
    [Abstract] [Full Text] [Related]

  • 2. Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients.
    Masjedi MR, Tabarsi P, Baghaei P, Jalali S, Farnia P, Chitsaz E, Amiri M, Mansouri D, Velayati AA.
    Int J Infect Dis; 2010 May; 14(5):e399-402. PubMed ID: 19818664
    [Abstract] [Full Text] [Related]

  • 3. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.
    Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154
    [Abstract] [Full Text] [Related]

  • 4. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
    Mirsaeidi SM, Tabarsi P, Khoshnood K, Pooramiri MV, Rowhani-Rahbar A, Mansoori SD, Masjedi H, Zahirifard S, Mohammadi F, Farnia P, Masjedi MR, Velayati AA.
    Int J Infect Dis; 2005 Nov 15; 9(6):317-22. PubMed ID: 16183321
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 15; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 7. Drug susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected and uninfected pulmonary tuberculosis patients in eastern India.
    Chakraborty N, De C, Bhattacharyya S, Mukherjee A, Santra S, Banerjee D, Sarkar RN, Guha SK.
    Trans R Soc Trop Med Hyg; 2010 Mar 15; 104(3):195-201. PubMed ID: 19828165
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study.
    Tabarsi P, Baghaei P, Jalali S, Farnia P, Chitsaz E, Mirsaeidi M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA.
    Scand J Infect Dis; 2009 Mar 15; 41(1):10-3. PubMed ID: 19037820
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S, Chandrasekar C, Mahilmaran A, Kanakaraj K, Karthikeyan DS, Suriakumar J.
    J Indian Med Assoc; 2009 May 15; 107(5):281-2, 284-6. PubMed ID: 19886382
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.
    Baghaei P, Tabarsi P, Dorriz D, Marjani M, Shamaei M, Pooramiri MV, Mansouri D, Farnia P, Masjedi M, Velayati A.
    Am J Ther; 2011 May 15; 18(2):e29-34. PubMed ID: 20019591
    [Abstract] [Full Text] [Related]

  • 15. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
    Yew WW.
    Kekkaku; 2011 Jan 15; 86(1):9-16. PubMed ID: 21401001
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.
    Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, Kim EK, Lee KM, Lee SS, Park JS, Koh WJ, Lee CH, Shim TS.
    Am J Respir Crit Care Med; 2010 Jul 01; 182(1):113-9. PubMed ID: 20224066
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB.
    Kliiman K, Altraja A.
    Eur Respir J; 2009 May 01; 33(5):1085-94. PubMed ID: 19164345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.